Exclusive Therapeutic Use of Cannabis in a Large Sample of Daily Cannabis Users in France: A Cross-Sectional Survey

References

• Aguilar, S., V. Gutiérrez, L. Sánchez, and M. Nougier. 2018. Medicinal cannabis policies and practices around the world. United Kingdom: International Drug Policy Consortium. https://idpc.net/publications/2018/04/medicinal-cannabis-policies-and-practices-around-the-world.
   Google Scholar
• Alavinia, S. M., and A. Burdorf. 2008. Unemployment and retirement and ill-health: A cross-sectional analysis across European countries. International Archives of Occupational and Environmental Health 82 (1):39–45. doi:10.1007/s00420-008-0304-6.
   PubMed Web of Science ®Google Scholar
• Askew, R., and L. Williams. 2021. Rethinking enhancement substance use: A critical discourse studies approach. International Journal of Drug Policy 95:102994. doi:10.1016/j.drugpo.2020.102994.
   PubMed Web of Science ®Google Scholar
• Aviram, J., and G. Samuelly-Leichtag. 2017. Efficacy of cannabis-based medicines for pain management: A systematic review and meta-analysis of randomized controlled trials. Pain Physician 20 (6):E755–E96. doi:10.36076/ppj.20.5.E755.
   PubMed Web of Science ®Google Scholar
• Babson, K. A., J. Sottile, and D. Morabito. 2017. Cannabis, cannabinoids, and sleep: A review of the literature. Current Psychiatry Reports 19 (4):1–12. doi:10.1007/s11920-017-0775-9.
   PubMed Web of Science ®Google Scholar
• Botsford, S. L., S. Yang, and T. P. George. 2020. Review: Cannabis and cannabinoids in mood and anxiety disorders: Impact on illness onset and course, and assessment of therapeutic potential. The American Journal on Addictions 29 (1):9–26. doi:10.1111/ajad.12963.
   PubMed Web of Science ®Google Scholar
• Bush, K., D. R. Kivlahan, M. B. McDonell, S. D. Fihn, and K. A. Bradley. 1998. The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). alcohol use disorders identification test. Archives of Internal Medicine 158 (16):1789–95. doi:10.1001/archinte.158.16.1789.
   PubMed Web of Science ®Google Scholar
• Campeny, E., H. López-Pelayo, D. Nutt, C. Blithikioti, C. Oliveras, L. Nuño, R. Maldonado, G. Florez, F. Arias, S. Fernández-Artamendi, et al. 2020. The blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms. European Neuropsychopharmacology 33:1–35. doi:10.1016/j.euroneuro.2020.02.003.
   PubMed Web of Science ®Google Scholar
• Chen, X., H. Orom, J. L. Hay, E. A. Waters, E. Schofield, Y. Li, and M. T. Kiviniemi. 2019. Differences in rural and urban health information access and use. The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association 35 (3):405–17. doi:10.1111/jrh.12335.
   PubMed Web of Science ®Google Scholar
• Choi, N. G., D. M. DiNitto, and C. N. Marti. 2017. Nonmedical versus medical marijuana use among three age groups of adults: Associations with mental and physical health status. The American Journal on Addictions 26 (7):697–706. doi:10.1111/ajad.12598.
   PubMed Web of Science ®Google Scholar
• Dahl, S. L., and J. Demant. 2017. “Don’t make too much fuss about it.” Negotiating adult cannabis use. Drugs: Education, Prevention & Policy 24 (4):324–31. doi:10.1080/09687637.2017.1325444.
   Web of Science ®Google Scholar
• Darke, S. 1998. Self-report among injecting drug users: A review. Drug and Alcohol Dependence 51 (3):253–63. doi:10.1016/S0376-8716(98)00028-3.
   PubMed Web of Science ®Google Scholar
• Decorte, T. 2001. Drug users’ perceptions of ‘controlled’ and ‘uncontrolled’ use. International Journal of Drug Policy 12 (4):297–320. doi:10.1016/S0955-3959(01)00095-0.
   Google Scholar
• Desroches, J., and P. Beaulieu. 2010. Opioids and cannabinoids interactions: Involvement in pain management. Current Drug Targets 11 (4):462–73. doi:10.2174/138945010790980303.
   PubMed Web of Science ®Google Scholar
• Dryburgh, L. M., N. S. Bolan, C. P. L. Grof, P. Galettis, J. Schneider, C. J. Lucas, and J. H. Martin. 2018. Cannabis contaminants: Sources, distribution, human toxicity and pharmacologic effects. British Journal of Clinical Pharmacology 84 (11):2468–76. doi:10.1111/bcp.13695.
   PubMed Web of Science ®Google Scholar
• Engel, L. B., S. J. Bright, M. J. Barratt, and M. M. Allen. 2021. Positive drug stories: Possibilities for agency and positive subjectivity for harm reduction. Addiction Research & Theory 29 (5):363–71. doi:10.1080/16066359.2020.1837781.
   Web of Science ®Google Scholar
• Goulet-Stock, S., S. Rueda, A. Vafaei, A. Ialomiteanu, J. Manthey, J. Rehm, and B. Fischer. 2017. Comparing medical and recreational cannabis users on socio-demographic, substance and medication use, and health and disability characteristics. European Addiction Research 23 (3):129–35. doi:10.1159/000475987.
   PubMed Web of Science ®Google Scholar
• Green, B., D. Kavanagh, and R. Young. 2003. Being stoned: A review of self-reported cannabis effects. Drug and Alcohol Review 22 (4):453–60. doi:10.1080/09595230310001613976.
   PubMed Web of Science ®Google Scholar
• Hartogsohn, I. 2017. Constructing drug effects: A history of set and setting. Drug Science, Policy and Law 3:2050324516683325. doi:10.1177/2050324516683325.
   Google Scholar
• Hazekamp, A., M. A. Ware, K. R. Muller-Vahl, D. Abrams, and F. Grotenhermen. 2013. The medicinal use of cannabis and cannabinoids—an international cross-sectional survey on administration forms. Journal of Psychoactive Drugs 45 (3):199–210. doi:10.1080/02791072.2013.805976.
   PubMed Web of Science ®Google Scholar
• Johnston, K. J., H. Wen, and K. E. Joynt Maddox. 2019. Lack of access to specialists associated with mortality and preventable hospitalizations of rural medicare beneficiaries. Health Affairs (Project Hope) 38 (12):1993–2002. doi:10.1377/hlthaff.2019.00838.
   PubMed Web of Science ®Google Scholar
• Kosiba, J. D., S. A. Maisto, and J. W. Ditre. 2019. Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Social Science & Medicine 233:181–92. doi:10.1016/j.socscimed.2019.06.005.
   PubMed Web of Science ®Google Scholar
• Kruger, D. J., and J. S. Kruger. 2019. Medical cannabis users’ comparisons between medical cannabis and mainstream medicine. Journal of Psychoactive Drugs 51 (1):31–36. doi:10.1080/02791072.2018.1563314.
   PubMed Web of Science ®Google Scholar
• Lau, N., P. Sales, S. Averill, F. Murphy, S.-O. Sato, and S. Murphy. 2015a. Responsible and controlled use: Older cannabis users and harm reduction. The International Journal on Drug Policy 26 (8):709–18. doi:10.1016/j.drugpo.2015.03.008.
   PubMed Web of Science ®Google Scholar
• Lau, N., P. Sales, S. Averill, F. Murphy, S.-O. Sato, and S. Murphy. 2015b. A safer alternative: Cannabis substitution as harm reduction. Drug and Alcohol Review 34 (6):654–59. doi:10.1111/dar.12275.
   PubMed Web of Science ®Google Scholar
• Le Nézet, O., A. Philippon, E. Lahaie, and R. Andler. 2021. Les niveaux d’usage de cannabis en France en 2020. (Note de Synthèse No. 2021–06; p. 6). Paris: Observatoire Français des Drogues et des Toxicomanies. https://www.ofdt.fr/publications/collections/notes/note-cannabis-barometre-sante/.
   Google Scholar
• Leroux, E., I. Taifas, D. Valade, A. Donnet, M. Chagnon, and A. Ducros. 2013. Use of cannabis among 139 cluster headache sufferers. Cephalalgia: An International Journal of Headache 33 (3):208–13. doi:10.1177/0333102412468669.
   PubMed Web of Science ®Google Scholar
• Li, X., J. P. Diviant, S. S. Stith, F. Brockelman, K. Keeling, B. Hall, and J. M. Vigil. 2020. The effectiveness of cannabis flower for immediate relief from symptoms of depression. The Yale Journal of Biology and Medicine 93 (2):251–64.
   PubMed Web of Science ®Google Scholar
• Lin, L. A., M. A. Ilgen, M. Jannausch, and K. M. Bohnert. 2016. Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample. Addictive Behaviors 61:99–103. doi:10.1016/j.addbeh.2016.05.015.
   PubMed Web of Science ®Google Scholar
• Lucas, P. 2012. Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain. Journal of Psychoactive Drugs 44 (2):125–33. doi:10.1080/02791072.2012.684624.
   PubMed Web of Science ®Google Scholar
• Malouff, J. M., S. E. Rooke, and J. Copeland. 2014. Experiences of marijuana-vaporizer users. Substance Abuse 35 (2):127–28. doi:10.1080/08897077.2013.823902.
   PubMed Web of Science ®Google Scholar
• McLellan, A. T., L. Luborsky, G. E. Woody, and C. P. O’brien. 1980. An improved diagnostic evaluation instrument for substance abuse patients: The addiction severity index. The Journal of Nervous and Mental Disease 168 (1):26–33. doi:10.1097/00005053-198001000-00006.
   PubMed Web of Science ®Google Scholar
• Mezaache, S., C. Donadille, V. Martin, M. Le Brun Gadelius, L. Appel, B. Spire, L. Briand Madrid, M. Bastien, and P. Roux. 2022. Changes in cannabis use and associated correlates during France’s first COVID-19 lockdown in daily cannabis users: Results from a large community-based online survey. Harm Reduction Journal 19 (1):26. doi:10.1186/s12954-022-00611-x.
   PubMed Web of Science ®Google Scholar
• Moore, D. 2008. Erasing pleasure from public discourse on illicit drugs: On the creation and reproduction of an absence. International Journal of Drug Policy 19 (5):353–58. doi:10.1016/j.drugpo.2007.07.004.
   PubMed Web of Science ®Google Scholar
• Nielsen, S., R. Germanos, M. Weier, J. Pollard, L. Degenhardt, W. Hall, N. Buckley, and M. Farrell. 2018. The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: A systematic review of reviews. Current Neurology and Neuroscience Reports 18 (2):8. doi:10.1007/s11910-018-0814-x.
   PubMed Web of Science ®Google Scholar
• Ogborne, A. C., R. G. Smart, T. Weber, and C. Birchmore-Timney. 2000. Who is using cannabis as a medicine and why: An exploratory study. Journal of Psychoactive Drugs 32 (4):435–43. doi:10.1080/02791072.2000.10400245.
   PubMed Web of Science ®Google Scholar
• Okusanya, B. O., I. O. Asaolu, J. E. Ehiri, L. J. Kimaru, A. Okechukwu, and C. Rosales. 2020. Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: A systematic review. Systematic Reviews 9 (1):167. doi:10.1186/s13643-020-01425-3.
   PubMed Web of Science ®Google Scholar
• Osborn, L. A., K. J. Lauritsen, N. Cross, A. K. Davis, H. Rosenberg, F. Bonadio, and B. Lang. 2015. Self-medication of somatic and psychiatric conditions using botanical marijuana. Journal of Psychoactive Drugs 47 (5):345–50. doi:10.1080/02791072.2015.1096433.
   PubMed Web of Science ®Google Scholar
• Park, J.-Y., and L.-T. Wu. 2017. Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review. Drug and Alcohol Dependence 177:1–13. doi:10.1016/j.drugalcdep.2017.03.009.
   PubMed Web of Science ®Google Scholar
• Pisanti, S., and M. Bifulco. 2019. Medical Cannabis: A plurimillennial history of an evergreen. Journal of Cellular Physiology 234 (6):8342–51. doi:10.1002/jcp.27725.
   PubMed Web of Science ®Google Scholar
• Reiman, A. 2009. Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal 6 (1):35. doi:10.1186/1477-7517-6-35.
   PubMed Web of Science ®Google Scholar
• Reinarman, C., H. Nunberg, F. Lanthier, and T. Heddleston. 2011. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. Journal of Psychoactive Drugs 43 (2):128–35. doi:10.1080/02791072.2011.587700.
   PubMed Web of Science ®Google Scholar
• Rey, G., E. Jougla, A. Fouillet, and D. Hémon. 2009. Ecological association between a deprivation index and mortality in France over the period 1997 – 2001: Variations with spatial scale, degree of urbanicity, age, gender and cause of death. BMC Public Health 9 (1):33. doi:10.1186/1471-2458-9-33.
   PubMedGoogle Scholar
• Rotermann, M., and M.-M. Pagé. 2018. Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015. Health Reports 29 (7):3–13.
   PubMed Web of Science ®Google Scholar
• Roy-Byrne, P., C. Maynard, K. Bumgardner, A. Krupski, C. Dunn, I. I. West, D. Donovan, D. C. Atkins, and R. Ries. 2015. Are medical marijuana users different from recreational users? The view from primary care. The American Journal on Addictions 24 (7):599–606. doi:10.1111/ajad.12270.
   PubMed Web of Science ®Google Scholar
• Russell, C., S. Rueda, R. Room, M. Tyndall, and B. Fischer. 2018. Routes of administration for cannabis use – basic prevalence and related health outcomes: A scoping review and synthesis. International Journal of Drug Policy 52:87–96. doi:10.1016/j.drugpo.2017.11.008.
   PubMed Web of Science ®Google Scholar
• Sarris, J., J. Sinclair, D. Karamacoska, M. Davidson, and J. Firth. 2020. Medicinal cannabis for psychiatric disorders: A clinically-focused systematic review. BMC Psychiatry 20 (1):24. doi:10.1186/s12888-019-2409-8.
   PubMed Web of Science ®Google Scholar
• Sexton, M., C. Cuttler, J. S. Finnell, and L. K. Mischley. 2016. A cross-sectional survey of medical cannabis users: Patterns of use and perceived efficacy. Cannabis and Cannabinoid Research 1 (1):131–38. doi:10.1089/can.2016.0007.
   PubMedGoogle Scholar
• Smith, L. A., F. Azariah, V. T. Lavender, N. S. Stoner, and S. Bettiol. 2015. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database of Systematic Reviews 2015 (11):CD009464. doi:10.1002/14651858.CD009464.pub2.
   PubMedGoogle Scholar
• Spilka, S., J.-B. Richard, O. Le Nézet, E. Janssen, A. Brissot, A. Philippon, J. Shah, S. Chyderiotis, R. Andler, and C. Cogordan. 2018. Les niveaux d’usages des drogues illicites en France en 2017 (No. 128; Tendances, p. 6). Paris: OFDT.
   Google Scholar
• St. Arnaud, K. O. 2021. Toward a positive psychology of psychoactive drug use. Drugs: Education, Prevention & Policy. 1–14. doi:10.1080/09687637.2021.2002816.
   Web of Science ®Google Scholar
• Stockings, E., D. Zagic, G. Campbell, M. Weier, W. D. Hall, S. Nielsen, G. K. Herkes, M. Farrell, and L. Degenhardt. 2018. Evidence for cannabis and cannabinoids for epilepsy: A systematic review of controlled and observational evidence. Journal of Neurology, Neurosurgery & Psychiatry 89 (7):741–53. doi:10.1136/jnnp-2017-317168.
   PubMed Web of Science ®Google Scholar
• Sznitman, S. R. 2017. Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups? The International Journal on Drug Policy 42:15–21. doi:10.1016/j.drugpo.2016.11.010.
   PubMed Web of Science ®Google Scholar
• Tunks, E. R., J. Crook, and R. Weir. 2008. Epidemiology of chronic pain with psychological comorbidity: Prevalence, risk, course, and prognosis. The Canadian Journal of Psychiatry 53 (4):224–34. doi:10.1177/070674370805300403.
   PubMed Web of Science ®Google Scholar
• Turna, J., I. Balodis, C. Munn, M. Van Ameringen, J. Busse, and J. MacKillop. 2020. Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users. Comprehensive Psychiatry 102:152188. doi:10.1016/j.comppsych.2020.152188.
   PubMed Web of Science ®Google Scholar
• Wall, M. M., J. Liu, D. S. Hasin, C. Blanco, and M. Olfson. 2019. Use of marijuana exclusively for medical purposes. Drug and Alcohol Dependence 195:13–15. doi:10.1016/j.drugalcdep.2018.11.009.
   PubMed Web of Science ®Google Scholar
• Walsh, Z., R. Callaway, L. Belle-Isle, R. Capler, R. Kay, P. Lucas, and S. Holtzman. 2013. Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use. International Journal of Drug Policy 24 (6):511–16. doi:10.1016/j.drugpo.2013.08.010.
   PubMed Web of Science ®Google Scholar
• Whiting, P. F., R. F. Wolff, S. Deshpande, M. Di Nisio, S. Duffy, A. V. Hernandez, J. C. Keurentjes, S. Lang, K. Misso, S. Ryder, et al. 2015. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA 313 (24):2456–73. doi:10.1001/jama.2015.6358.
   PubMed Web of Science ®Google Scholar
• Winiger, E. A., L. N. Hitchcock, A. D. Bryan, and L. Cinnamon Bidwell. 2021. Cannabis use and sleep: Expectations, outcomes, and the role of age. Addictive Behaviors 112:106642. doi:10.1016/j.addbeh.2020.106642.
   PubMed Web of Science ®Google Scholar
• World Drug Report 2019. 2019. United nations office on drugs and crime.
   Google Scholar
• Zinberg, N. E., and W. M. Harding. 1979. Control and intoxicant use: A theoretical and practical overview. Journal of Drug Issues 9 (2):121–43. doi:10.1177/002204267900900201.
   Web of Science ®Google Scholar